(Ann Rheum Dis 1994; 53: 759-762) 
Genetic and environmental factors influence the prevalence of hyperuricaemia and gout in various ethnic groups`'3 and urban and rural populations. 4 5 Gout was reported to be uncommon in black Africans6`Q and this was confirmed in a previous survey from our hospital. '0 More recent studies have reported a greater prevalence of gout in black Africans" 12 and a higher prevalence has also been reported in a black American population.'3 Although a genetic predisposition to gout is well recognised, no association with HLA antigens has been reported.
In view of the relative rarity of gout in black Africans, we studied the HLA class I and class II antigens to determine if these antigens were associated with the development of gout. In addition, we defined the clinical characteristics of gout in black Africans. the diagnosis of gout preceded that of the two other conditions and these patients were classified as having primary gout. A history of alcohol intake was recorded in 92 patients. Seventy three patients (79%) gave a history of alcohol intake, but details as to the type and amount of alcohol consumed were not available. Table 2 compares patients with primary gout and those with secondary gout. An older age at onset (53 years) was noted in secondary gout, compared with 48&3 years in primary gout (p = 005). Secondary gout was more common in females (78&6%) compared with males (44%) (p < 0 05). There was no significant difference in duration of disease, mode of presentation or pattern of joint involvement between the primary and secondary groups.
Patients and methods
In the HLA study there was a significant increase in the frequencies of the A28, B14, Cwl, DR8 and DQw3 antigens in patients with primary gout and of A28, B17 and Cw3 antigens in patients with secondary gout compared with control subjects (table 3) . After correction for the number of antigens tested, only B 14 remained significantly increased in patients with primary gout (p(exact) = 0005). Further correction for the two groups of patients also showed a significant increase for B14 (p < 0 01). Comparing primary and secondary gout (table 3), the B14 antigen was present in 26 -1% of patients with primary gout and 4.4% of patients with secondary gout (X2 = 4-21; p(exact) = 0O048), whilst the B70 antigen was present in 43% of patients with secondary gout and 8-7% of patients with primary gout (X2= 7-22; p(exact) = 00083).
Corrected p values did not reach statistical significance. Discussion Gout has been recognised as an uncommon disease in black Africans. Small numbers of patients with gout were reported from The majority of our patients (62.6%) presented with involvement of more than one joint compared with only 1 1% of patients in the British series.2' This may be explained in part by the inclusion of outpatients in the British series, whereas we studied mainly hospital inpatients who are likely to have more severe disease; also, older female patients were included in our series. Lawry et a128 reported that polyarticular gout reflected chronicity associated with poor patient understanding, poor patient compliance and suboptimal physician management. In addition, serum concentrations of monosodium urate may be normal in polyarticular gout. 29 Raddatz et al30 reported that 19 of their 41 patients with polyarticular gout were misdiagnosed initially and we also encountered similar patients.
Previous studies of 66 white patients with gout'5 and 22 males with gout and 105 of their first degree relatives'4 did not detect any significant difference in the frequency of HLA compared with controls. We found a significant increase in the frequency of HLA-B 14 in patients with primary gout but the clinical significance of this finding is uncertain and may be the result of a sample bias. An increased prevalence of HLA-B14 antigen has also been reported in black South Africans with insulin dependent diabetes3' and Graves' disease32 but none of our B 14 positive patients had either of these diseases.
Conclusions
In this hospital based study we confirm that gout is more common in black Africans than previously recorded. This may be the result of environmental factors associated with increasing urbanization in a country undergoing socio-economic and political change, genetic factors, or an increased awareness of the disease. On the basis of this study we suggest that, among black Africans, gout must be included in the differential diagnosis of pauciarthritis or polyarthritis in males and postmenopausal females. A weak association with HLA-B 14 has been noted in patients with primary gout and further studies are needed to determine if this is of any clinical significance.
